NCT00409773
Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)
See it on ClinicalTrials.gov ↗1,143 people
43.6%
56.4%
498 womenmiddle line = equal numbers645 men
- Phase
- PHASE3
- Paid for by
- Organon and Co
- Finished
- 2008-07
- Health conditions
- Hypercholesterolemia, Metabolic Syndrome
- Who could join
- Anyone
- Ages
- 18 Years – 79 Years
- Average age
- mean 59.1 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 74.9% · Other 11% · Asian 7.5% · Black / African American 6.6%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant or lactating women, women intending to become pregnant”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnant or lactating women, women intending to become pregnant”
- No diabetes
Women with diabetes were turned away.
“Patient with Type 1 or Type 2 diabetes mellitus that is poorly controlled, newly diagnosed, or is taking new or recently adjusted antidiabetic pharmacotherapy (with the exception of +/- 10 units of insulin)”
Study titles and rules are shown in their original English.